Anti-HIV agents. Receptor blocker (SCH 532706) enters clinical trials.
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D065100:CCR5 Receptor Antagonists; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D019562:Viral Load
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists